Aktieanalys

NeoDynamics: Commercial orders from prolific centers - Redeye

Redeye Publicerad: 20 Sep 2021 11:50

Redeye welcomes the continued commercial orders for NeoDynamics in Germany and Switzerland. We believe that its ramp-up awaits the lift of corona-related restrictions but are encouraged by its efforts and successes in introducing NeoNavia to prolific breast cancer centers. In addition to its activities in the European market, we anticipate an FDA filing before year-end that could open up the doors for the much bigger US market. Today’s news does not render any changes to our current Base Case, which stands at SEK 4 per share.

Länk till analysen i sin helhet: https://www.redeye.se/research/821041/neodynamics-commercial-orders-from-prolific-centers?utm_source=finwire&utm_medium=RSS

Nyheter om NeoDynamics

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!